Concepedia

Richard Graham

RG

59

Publications

6K

Citations

35

H-Index

1969

Active since

Affiliations

The Barbara Ann Karmanos Cancer Institute(Current)

University of California, Riverside

Theravance Biopharma (United States)

Mayo Clinic in Arizona

University of North Carolina at Chapel Hill

Richard Graham is an author at The Barbara Ann Karmanos Cancer Institute specializing in chemistry, engineering, and natural sciences.

Top concepts

Publications per year

1969–2021

59

Publications

59

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma

Aleksandar Sekulić, Michael R. Migden, Anthony E. Oro et al. · New England Journal of Medicine · 2012 · 1.4K citations · Full text

Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors

Patricia LoRusso, Charles M. Rudin, Josina C. Reddy et al. · Clinical Cancer Research · 2011 · 544 citations · Full text

CYP3A4 Induction by Drugs: Correlation between a Pregnane X Receptor Reporter Gene Assay and CYP3A4 Expression in Human Hepatocytes

Gang Luo, Mark R. Cunningham, Sean Kim et al. · Drug Metabolism and Disposition · 2002 · 446 citations

Effects of Prototypical Microsomal Enzyme Inducers on Cytochrome P450 Expression in Cultured Human Hepatocytes

Ajay Madan, Richard Graham, Kathleen Carroll et al. · Drug Metabolism and Disposition · 2003 · 337 citations

Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Jagath R. Junutula, Kelly M. Flagella, Richard Graham et al. · Clinical Cancer Research · 2010 · 289 citations

Rows per page

1–5 of 59